JP2001500101A - 乳癌の治療及び予防のための医薬組成物の製造のためのセントクロマンのｌ―鏡像異性体の使用 - Google Patents

乳癌の治療及び予防のための医薬組成物の製造のためのセントクロマンのｌ―鏡像異性体の使用

Info

Publication number
JP2001500101A
JP2001500101A JP09524767A JP52476797A JP2001500101A JP 2001500101 A JP2001500101 A JP 2001500101A JP 09524767 A JP09524767 A JP 09524767A JP 52476797 A JP52476797 A JP 52476797A JP 2001500101 A JP2001500101 A JP 2001500101A
Authority
JP
Japan
Prior art keywords
breast cancer
enantiomer
phenyl
treatment
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP09524767A
Other languages
English (en)
Japanese (ja)
Inventor
サルミ，ミハエル
プラカシュ カンボイ，ベデ
プラサド アスタナ，オムカー
レイ，スプラブハット
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of JP2001500101A publication Critical patent/JP2001500101A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP09524767A 1996-01-11 1997-01-09 乳癌の治療及び予防のための医薬組成物の製造のためのセントクロマンのｌ―鏡像異性体の使用 Pending JP2001500101A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1000096P 1996-01-11 1996-01-11
DK60/010,000 1996-07-11
DK77696 1996-07-11
DK0776/96 1996-07-11
PCT/DK1997/000007 WO1997025034A1 (en) 1996-01-11 1997-01-09 Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer

Publications (1)

Publication Number Publication Date
JP2001500101A true JP2001500101A (ja) 2001-01-09

Family

ID=26064631

Family Applications (1)

Application Number Title Priority Date Filing Date
JP09524767A Pending JP2001500101A (ja) 1996-01-11 1997-01-09 乳癌の治療及び予防のための医薬組成物の製造のためのセントクロマンのｌ―鏡像異性体の使用

Country Status (12)

Country Link
EP (1) EP0873119A1 (hu)
JP (1) JP2001500101A (hu)
KR (1) KR19990077157A (hu)
AU (1) AU1367197A (hu)
BR (1) BR9706966A (hu)
CA (1) CA2241462A1 (hu)
CZ (1) CZ217198A3 (hu)
HU (1) HUP9901633A3 (hu)
IL (1) IL124881A0 (hu)
NO (1) NO983177L (hu)
PL (1) PL328135A1 (hu)
WO (1) WO1997025034A1 (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1028724A1 (en) * 1997-11-10 2000-08-23 Novo Nordisk A/S Transdermal delivery of 3,4-diarylchromans
AU2011253842B2 (en) * 1998-06-11 2014-08-14 Endorecherche Inc. Medical Uses of a Selective Estrogen Receptor Modulator in Combination with Sex Steroid Precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
AU2004200099B2 (en) * 1998-06-11 2006-11-02 Endorecherche, Inc. Medical Uses of A Selective Estrogen Receptor Modulator in Combination with Sex Steroid Precursors
MX2007004830A (es) 2004-10-20 2007-10-04 Endorech Inc Precursores esteroides sexuales solos o en combinacion con un modulador receptor de estrogeno selectivo y/o con estrogenos y/o con un inhibidor de fosfodiesterasa gmpc de tipo 5 para la prevencion y tratamiento de resequedad vaginal y disfuncion sexu
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
ME00996B (me) 2007-10-16 2012-10-20 Repros Therapeutics Inc Trans-klomifen za liječenje metaboličkog sindroma
US20100317635A1 (en) 2009-06-16 2010-12-16 Endorecherche, Inc. Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
KR20150039882A (ko) 2010-06-16 2015-04-13 앙도르쉐르슈 인코포레이티드 에스트로겐-관련 질병의 치료 또는 예방 방법
CA2865234A1 (en) 2012-02-29 2013-09-06 Repros Therapeutics Inc. Combination therapy for treating androgen deficiency
US9744177B2 (en) 2014-03-10 2017-08-29 Endorecherche, Inc. Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
AU2016352592B2 (en) 2015-11-10 2023-04-27 Paracrine Therapeutics Ab Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and an anti estrogen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447622A (en) * 1981-09-22 1984-05-08 Council Of Scientific And Industrial Research Rafi Marg Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof

Also Published As

Publication number Publication date
PL328135A1 (en) 1999-01-18
CZ217198A3 (cs) 1998-11-11
IL124881A0 (en) 1999-01-26
HUP9901633A2 (hu) 1999-10-28
EP0873119A1 (en) 1998-10-28
WO1997025034A1 (en) 1997-07-17
KR19990077157A (ko) 1999-10-25
BR9706966A (pt) 1999-05-04
CA2241462A1 (en) 1997-07-17
AU1367197A (en) 1997-08-01
HUP9901633A3 (en) 2000-02-28
NO983177L (no) 1998-07-10

Similar Documents

Publication Publication Date Title
AU2009200258B2 (en) Methods of treating and/or suppressing weight gain
CA2522761C (en) Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
JP2000506508A (ja) 良性前立腺肥大の治療又は予防のための医薬組成物の製造のための３，４―ジフェニルクロマンの使用
JP2001500101A (ja) 乳癌の治療及び予防のための医薬組成物の製造のためのセントクロマンのｌ―鏡像異性体の使用
JP2000506506A (ja) 皮膚及び／又は粘膜の萎縮症の治療又は予防のための医薬組成物の製造のための３，４―ジフェニルクロマンの使用
JPH10511962A (ja) 婦人科疾患の治療または予防用の医薬組成物の製造への３，４−ジフェニルクロマンの使用
EP0873122B1 (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
KR19990077156A (ko) 폐경기 증상의 치료 또는 예방을 위한 약학적 조성물의제조를 위한 3,4-디페닐크로만의 사용
JP2002505280A (ja) 一過性熱感を軽減するための塩酸フルオキセチン
US5756539A (en) 3, 4-diphenyl chromans for inhibiting one or more psychiatric disorders
JPH10511961A (ja) 高リポプロテイン血症、高トリグリセリド血症、高脂血症又は高コレステロール血症の治療又は予防のための、又は抗血液凝固処置のための医薬組成物の製造のための３，４−ジフェニル・クロマンの使用
JPH08507774A (ja) 手術後の悪心および嘔吐の治療のためのグラニセトロンの使用
US6008242A (en) Use of 1-centchroman for the manufacture of a pharmaceutical composition for the treatment of obesity
JP2000514441A (ja) 月経前症候群の１又は複数の症状を抑制するための医薬組成物の製造のための３，４―ジフェニルクロマンの使用
US5780502A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome
JPH10513154A (ja) 血管拡張治療または予防用の医薬組成物の製造への３，４−ジフェニルクロマンの使用
JPH10511960A (ja) 特発性の又は生理学的な女性化乳房の治療又は予防のための医薬製剤の製造のための３，４−ジフェニル・クロマンの使用
JP2999539B2 (ja) 白血球減少症の予防・治療剤
CN1207037A (zh) 西替考马l－对映体在制备治疗或预防乳癌药物组合物中的应用
CN1207038A (zh) 3,4－二苯基苯并二氢吡喃在生产预防或治疗绝经症状的药物组合物中的应用
WO1999048497A1 (en) USE OF 3,4-DIPHENYLCHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR LOWERING PLASMA LEVELS OF Lp(a) IN A HUMAN OR SUB-HUMAN PRIMATE